Trial · NCT03673462
Adverse events190
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 190
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Diarrhoea | Gastrointestinal disorders | Group 1: MenACYW Conjugate Vaccine | 85 | 2,080 | 92 |
| other | Diarrhoea | Gastrointestinal disorders | Group 2: MENVEO® | 37 | 697 | 39 |
| other | Teething | Gastrointestinal disorders | Group 1: MenACYW Conjugate Vaccine | 161 | 2,080 | 200 |
| other | Teething | Gastrointestinal disorders | Group 2: MENVEO® | 60 | 697 | 68 |
| other | Vomiting | Gastrointestinal disorders | Group 1: MenACYW Conjugate Vaccine | 579 | 2,080 | 807 |
| other | Vomiting | Gastrointestinal disorders | Group 2: MENVEO® | 172 | 697 | 253 |
| other | Crying | General disorders | Group 1: MenACYW Conjugate Vaccine | 1,439 | 2,080 | 3,327 |
| other | Crying | General disorders | Group 2: MENVEO® | 479 | 697 | 1,125 |
| other | Injection Site Bruising | General disorders | Group 1: MenACYW Conjugate Vaccine | 353 | 2,080 | 742 |
| other | Injection Site Bruising | General disorders | Group 2: MENVEO® | 107 | 697 | 223 |
| other | Injection Site Erythema | General disorders | Group 1: MenACYW Conjugate Vaccine | 1,129 | 2,080 | 6,150 |
| other | Injection Site Erythema | General disorders | Group 2: MENVEO® | 380 | 697 | 2,025 |
| other | Injection Site Pain | General disorders | Group 1: MenACYW Conjugate Vaccine | 1,619 | 2,080 | 13,051 |
| other | Injection Site Pain | General disorders | Group 2: MENVEO® | 538 | 697 | 4,340 |
| other | Injection Site Swelling | General disorders | Group 1: MenACYW Conjugate Vaccine | 871 | 2,080 | 3,790 |
| other | Injection Site Swelling | General disorders | Group 2: MENVEO® | 282 | 697 | 1,196 |
| other | Pyrexia | General disorders | Group 1: MenACYW Conjugate Vaccine | 810 | 2,080 | 1,280 |
| other | Pyrexia | General disorders | Group 2: MENVEO® | 248 | 697 | 360 |
| other | Otitis Media | Infections and infestations | Group 1: MenACYW Conjugate Vaccine | 148 | 2,080 | 176 |
| other | Otitis Media | Infections and infestations | Group 2: MENVEO® | 47 | 697 | 56 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03673462/events